Loading...

FONAR Corporation

FONRNASDAQ
Healthcare
Medical - Devices
$15.96
$-0.11(-0.68%)

FONAR Corporation (FONR) Stock Overview

Explore FONAR Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.9/100

Key Financials

Market Cap99.4M
P/E Ratio8.90
EPS (TTM)$1.25
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Week$15.05
1 Month$15.52
3 Months$12.12
1 Year Target$15.26

FONR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of FONAR Corporation (FONR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.90 and a market capitalization of 99.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;